questionsmedicales.fr
Produits chimiques inorganiques
Minéraux
Oxyde ferrosoferrique
Oxyde ferrosoferrique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxyde ferrosoferrique : Questions médicales les plus fréquentes",
"headline": "Oxyde ferrosoferrique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxyde ferrosoferrique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxyde ferrosoferrique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Minéraux",
"url": "https://questionsmedicales.fr/mesh/D008903",
"about": {
"@type": "MedicalCondition",
"name": "Minéraux",
"code": {
"@type": "MedicalCode",
"code": "D008903",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D01.578"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Oxyde ferrosoferrique",
"alternateName": "Ferrosoferric Oxide",
"code": {
"@type": "MedicalCode",
"code": "D052203",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mengqiang Zhu",
"url": "https://questionsmedicales.fr/author/Mengqiang%20Zhu",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecosystem Science and Management, University of Wyoming, Laramie, Wyoming 82071, United States."
}
},
{
"@type": "Person",
"name": "Sirajul Haq",
"url": "https://questionsmedicales.fr/author/Sirajul%20Haq",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Azad Jammu and Kashmir Muzaffarabad 13100 Pakistan."
}
},
{
"@type": "Person",
"name": "Michal Lojka",
"url": "https://questionsmedicales.fr/author/Michal%20Lojka",
"affiliation": {
"@type": "Organization",
"name": "Department of Inorganic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic."
}
},
{
"@type": "Person",
"name": "Ondřej Jankovský",
"url": "https://questionsmedicales.fr/author/Ond%C5%99ej%20Jankovsk%C3%BD",
"affiliation": {
"@type": "Organization",
"name": "Department of Inorganic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic. Ondrej.Jankovsky@vscht.cz."
}
},
{
"@type": "Person",
"name": "David Sedmidubský",
"url": "https://questionsmedicales.fr/author/David%20Sedmidubsk%C3%BD",
"affiliation": {
"@type": "Organization",
"name": "Department of Inorganic Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Technická 5, 166 28 Prague 6, Czech Republic. sedmidub@vscht.cz."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Localized scleroderma].",
"datePublished": "2024-02-16",
"url": "https://questionsmedicales.fr/article/38363312",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00105-024-05297-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Juvenile Scleroderma.",
"datePublished": "2023-11-15",
"url": "https://questionsmedicales.fr/article/37966656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12098-023-04894-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Whole genome sequencing and annotation of Scleroderma yunnanense, the only edible Scleroderma species.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37839651",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ygeno.2023.110727"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Juvenile localized scleroderma].",
"datePublished": "2024-01-19",
"url": "https://questionsmedicales.fr/article/38240812",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00105-023-05293-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human otopathology in scleroderma.",
"datePublished": "2023-11-15",
"url": "https://questionsmedicales.fr/article/38130272",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/lio2.1180"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques inorganiques",
"item": "https://questionsmedicales.fr/mesh/D007287"
},
{
"@type": "ListItem",
"position": 3,
"name": "Minéraux",
"item": "https://questionsmedicales.fr/mesh/D008903"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxyde ferrosoferrique",
"item": "https://questionsmedicales.fr/mesh/D052203"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxyde ferrosoferrique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxyde ferrosoferrique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxyde ferrosoferrique",
"description": "Comment diagnostiquer une exposition à l'oxyde ferrosoferrique ?\nQuels tests sont utilisés pour évaluer l'oxyde ferrosoferrique ?\nQuels symptômes indiquent une intoxication par l'oxyde ferrosoferrique ?\nY a-t-il des marqueurs biologiques pour l'oxyde ferrosoferrique ?\nComment évaluer la toxicité de l'oxyde ferrosoferrique ?",
"url": "https://questionsmedicales.fr/mesh/D052203?mesh_terms=Scleroderma,+Diffuse&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxyde ferrosoferrique",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nL'oxyde ferrosoferrique cause-t-il des effets à long terme ?\nQuels signes indiquent une intoxication chronique ?\nPeut-on avoir des réactions allergiques à l'oxyde ferrosoferrique ?\nQuels symptômes respiratoires sont associés à l'oxyde ferrosoferrique ?",
"url": "https://questionsmedicales.fr/mesh/D052203?mesh_terms=Scleroderma,+Diffuse&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxyde ferrosoferrique",
"description": "Comment prévenir l'exposition à l'oxyde ferrosoferrique ?\nQuelles mesures de sécurité en milieu industriel ?\nY a-t-il des recommandations pour le stockage ?\nComment éduquer les travailleurs sur les risques ?\nQuels équipements de protection sont recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D052203?mesh_terms=Scleroderma,+Diffuse&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxyde ferrosoferrique",
"description": "Quel traitement pour l'intoxication par l'oxyde ferrosoferrique ?\nComment gérer les symptômes d'exposition ?\nY a-t-il un antidote spécifique pour l'oxyde ferrosoferrique ?\nQuand consulter un médecin après exposition ?\nQuels soins de suivi sont nécessaires après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D052203?mesh_terms=Scleroderma,+Diffuse&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxyde ferrosoferrique",
"description": "Quelles complications peuvent survenir après exposition ?\nL'oxyde ferrosoferrique peut-il causer des cancers ?\nQuels effets sur la santé mentale ?\nY a-t-il des risques pour les enfants ?\nComment surveiller les complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D052203?mesh_terms=Scleroderma,+Diffuse&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxyde ferrosoferrique",
"description": "Qui est à risque d'exposition à l'oxyde ferrosoferrique ?\nQuels facteurs augmentent le risque d'intoxication ?\nLes personnes âgées sont-elles plus à risque ?\nY a-t-il des prédispositions génétiques ?\nComment l'environnement influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D052203?mesh_terms=Scleroderma,+Diffuse&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition à l'oxyde ferrosoferrique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests sanguins pour mesurer les niveaux de fer."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'oxyde ferrosoferrique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et des tests d'imagerie peuvent être utilisés pour évaluer l'exposition."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication par l'oxyde ferrosoferrique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des nausées et des vomissements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour l'oxyde ferrosoferrique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de ferritine et de fer sérique peuvent servir de marqueurs."
}
},
{
"@type": "Question",
"name": "Comment évaluer la toxicité de l'oxyde ferrosoferrique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des tests cliniques et l'historique d'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des vomissements et de la diarrhée."
}
},
{
"@type": "Question",
"name": "L'oxyde ferrosoferrique cause-t-il des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des problèmes hépatiques et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une intoxication chronique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fatigue, des douleurs articulaires et des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des réactions allergiques à l'oxyde ferrosoferrique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques cutanées."
}
},
{
"@type": "Question",
"name": "Quels symptômes respiratoires sont associés à l'oxyde ferrosoferrique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition peut provoquer une irritation des voies respiratoires et des toux."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition à l'oxyde ferrosoferrique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de la manipulation de ce composé."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité en milieu industriel ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des systèmes de ventilation et des protocoles de sécurité stricts."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour le stockage ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Stocker l'oxyde ferrosoferrique dans des conteneurs hermétiques et étiquetés."
}
},
{
"@type": "Question",
"name": "Comment éduquer les travailleurs sur les risques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des formations régulières sur les risques et les mesures de sécurité."
}
},
{
"@type": "Question",
"name": "Quels équipements de protection sont recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des gants, des masques respiratoires et des lunettes de protection sont recommandés."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'intoxication par l'oxyde ferrosoferrique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des chélateurs de fer et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes d'exposition ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des antiémétiques et des fluides intraveineux."
}
},
{
"@type": "Question",
"name": "Y a-t-il un antidote spécifique pour l'oxyde ferrosoferrique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, mais des traitements symptomatiques sont disponibles."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin après exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin immédiatement si des symptômes d'intoxication apparaissent."
}
},
{
"@type": "Question",
"name": "Quels soins de suivi sont nécessaires après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier pour surveiller les niveaux de fer et la fonction hépatique est recommandé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des lésions hépatiques et des troubles respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'oxyde ferrosoferrique peut-il causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre l'exposition prolongée et certains cancers."
}
},
{
"@type": "Question",
"name": "Quels effets sur la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition chronique peut entraîner des troubles de l'humeur et de la cognition."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les enfants ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants sont plus vulnérables aux effets toxiques de l'oxyde ferrosoferrique."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens médicaux réguliers et des tests de fonction hépatique sont nécessaires."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'exposition à l'oxyde ferrosoferrique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et minière sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'intoxication ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée et un manque d'équipement de protection augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines prédispositions génétiques peuvent augmenter la sensibilité à l'intoxication."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre près d'industries polluantes peut augmenter le risque d'exposition."
}
}
]
}
]
}
Localized scleroderma (LS), also called circumscribed scleroderma or morphea, comprises a heterogeneous group of diseases that can be classified into four subtypes: limited, linear, generalized, and m...
Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-dis...
Scleroderma yunnanense, an ectomycorrhizal fungus, is a popular edible mushroom within the Yunnan Province of Southwest China that holds great ecological and economic implications. However, despite it...
Juvenile scleroderma, often referred to as juvenile localized scleroderma or "morphea", is a rare inflammatory disease of the skin and skin-related structures, accompanied by local sclerosis and tissu...
Scleroderma is a complex chronic progressive immune-mediated disease that causes fibrosis of the skin and internal organs, and vasculopathy.Ear involvement has been poorly studied in patients with scl...
The national temporal bone database was reviewed for cases with scleroderma. Clinical case review and correlative otopathologic analysis. Middle and inner ear otopathologic analysis was performed foll...
Two patients (three cases) with a history of serologically confirmed scleroderma were identified. Both individuals reported tinnitus and demonstrated bilateral moderate to severe down-sloping sensorin...
Fibrosis, inflammation, and vascular changes were observed in the middle and inner ear in patients with scleroderma. Findings have implications for understanding hearing and vestibular dysfunction in ...
Retrospective study....
Here, the efficacy of abatacept in patients with early diffuse systemic sclerosis (dcSSc) was analyzed to test the hypothesis that patients in the inflammatory intrinsic subset would show the most sig...
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by inflammation, vasculopathy and fibrosis of the skin and internal organs. Treatment with autologous hematopoietic cell transpla...
We present a patient with diffuse cutaneous SSc and associated interstitial lung disease (ILD) who successfully underwent a second HCT for progressive disease five years after a first HCT. We describe...
This case adds to the current limited literature on efficacy and safety of a second HCT in SSc refractory cases. Furthermore it outlines the potential of HCT on amelioration of microvasculopathy in SS...
Centromere defects in Systemic Sclerosis (SSc) have remained unexplored despite the fact that many centromere proteins were discovered in patients with SSc. Here we report that lesion skin fibroblasts...
Systemic sclerosis (SSc) is a rare autoimmune disease associated with high morbidity and mortality. SSc treatment is still challenging, and evidence is scarce. In the last decades high-dose chemothera...
32 patients who underwent HD-ASCT at our hospital between June 2000 and September 2020 were included. Clinical characteristics were evaluated based on chart review before and after HD-ASCT. Analyses f...
Median OS was 81 months (range 0-243). Within one year, 20 of 32 (76.9%) patients responded to HD-ASCT. Overall, 6 patients (18.8%) died in the context of HD-ASCT. Patients with subjective response to...
This study confirms the efficacy of HD-ASCT for patients with SSc in a single center real-world setting. High TRM is still a challenge. However, TRM could be reduced by exclusion of high-risk patients...
Interstitial lung disease (ILD) is the most common cause of death in patients with systemic sclerosis (SSc). Prognostic biomarkers are needed to identify SSc-ILD patients at risk for progressive pulmo...
Fifteen patients with new onset SSc-ILD underwent bronchoscopy. Autoantibody levels were analyzed using addressable laser bead immunoassay from BAL fluid and the serum. In a separate longitudinal coho...
Among SSc-ILD patients who were positive for anti-Ro52 (N = 5), 3 (60%) had enrichment of anti-Ro52 in BAL fluid at a ratio exceeding 50x. In the longitudinal cohort, 10/43 patients (23%) were anti-Ro...
This study suggests that antibodies targeting Ro52 are enriched in the lungs of patients with new-onset SSc-ILD, linking Ro52 autoimmunity to the pulmonary pathology of SSc. Clinical and immunohistoch...